Liver fat imaging-a clinical overview of ultrasound, CT, and M R imaging

British Journal of Radiology

Volumn 91, Issue 1089, 2018, Pages

  Zhang, Yingzhenn ^a   Fowler, Kathryn J ^b   Hamilton, Gavin ^a   Cui, Jennifer Y ^a   Sy, Ethan Z ^a   Balanay, Michelle ^a   Hooker, Jonathan C ^a   Szeverenyi, Nikolaus ^a   Sirlin, Claude B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DUAL ENERGY COMPUTED TOMOGRAPHY; ECHOGRAPHY; FATTY LIVER; HEPATOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; LIVER; NONALCOHOLIC FATTY LIVER; X-RAY COMPUTED TOMOGRAPHY;

HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; NON-ALCOHOLIC FATTY LIVER DISEASE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 85052561739     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20170959     Document Type: Review

References (85)

1. Fabbrini E, Sullivan S, Klein S, Ekstedt M, Hagstrom H, Nasr P. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010; 51: 679-89. doi: https://doi.org/10.1002/hep.23280
2. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 2012; 107: 811-26. doi: https://doi.org/10.1038/ajg.2012.128
3. Younossi Z M, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73-84. doi: https://doi.org/10.1002/hep.28431
4. Williams CD, Stengel J, Asike M I, Torres D M, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-31. doi: https://doi.org/10.1053/j.gastro.2010.09.038
5. Kim H, Lee K, Lee KW, Yi NJ, Lee HW, Hong G, et al. Histologically proven non¬ alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. Clin Transplant 2014; 28: 521-9. doi: https://doi.org/10.1111/ctr.12343
6. Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015; 61: 1547-54. doi: https://doi.org/10.1002/hep.27368
7. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-73. doi: https://doi. org/10.1002/hep.21327
8. Graffy PM, Pickhardt PJ. Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. Br J Radiol 2016; 89: 20151024. doi: https://doi.org/10.1259/bjr.20151024
9. Pickhardt PJ, Hahn L, Munoz del Rio A, Park SH, Reeder SB, Said A. Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications. AJR Am J Roentgenol 2014; 202: 752-8. doi: https://doi.org/10.2214/AJR.13.11367
10. Hahn L, Reeder SB, Munoz del Rio A, Pickhardt PJ. Longitudinal changes in liver fat content in asymptomatic adults: hepatic attenuation on unenhanced CT as an imaging biomarker for steatosis. AJR Am J Roentgenol 2015; 205: 1167-72. doi: https://doi.org/10.2214/AJR.15.14724
11. Brouha SS, Nguyen P, Bettencourt R, Sirlin CB, Loomba R. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: a prospective study. Eur Radiol 2018; 28: 1345-55. doi: https://doi.org/10.1007/s00330-017-5075-6
12. Graner M, Nyman K, Siren R, Pentikainen MO, Lundbom J, Hakkarainen A, et al. Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease. Circ Cardiovasc Imaging 2015; 8: e001979. doi: https://doi.org/10.1161/CIRCIMAGING.114. 001979
13. Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N, Younossi Z M . Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum Pathol 2004; 35: 196-9. doi: https://doi.org/10.1016/j.humpath.2003.09.018
14. Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2015; 149: 389-97. doi: https://doi.org/10.1053/j.gastro. 2015.04.043
15. Fassio E, Alvarez E, Dommguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 2004; 40: 820-6. doi: https://doi.org/10.1002/hep.20410
16. Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-74. doi: https://doi.org/10.1136/gut.2009.205088
17. Ajmera V, Park CC, Caussy C, Singh S, Hernandez C, Bettencourt R, et al. Magnetic resonance imaging proton density fat fraction associates with progression of fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 2018; In Press. doi: https://doi.org/10.1053/j.gastro.2018.04. 014
18. Patel J, Bettencourt R, Cui J, Salotti J, Hooker J, Bhatt A, et al. Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. Therap Adv Gastroenterol 2016; 9: 692-701. doi: https://doi.org/10.1177/1756283X16656735
19. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21. doi: https://doi.org/10.1002/hep.20701
20. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74. doi: https://doi.org/10.1111/j.1572-0241.1999.01377.x
21. El-Badry A M, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, et al. Assessment of hepatic steatosis by expert pathologists. Ann Surg 2009; 250: 691-7. doi: https://doi.org/10.1097/SLA. 0b013e3181bcd6dd
22. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-906. doi: https://doi.org/10.1053/).gastro.2005.03.084
23. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1 : 523-5. doi: https://doi.org/10.1016/S0140-6736(86)90883-4
24. A r u n J, Jhala N, Lazenby AJ, Clements R, Abrams GA. Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis i n subjects undergoing gastric bypass. Obes Surg 2007; 17: 155-61. doi: https://doi.org/10.1007/s11695-007-9041-2
25. Zwiebel WJ. Sonographic diagnosis of diffuse liver disease. Semin Ultrasound CT MR 1995; 16: 8-15. doi: https://doi.org/10.1016/0887-2171(95)90011-X
26. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis 2007; 11: 37-54. doi: https://doi.org/10.1016/j.cld.2007.02.014
27. Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, Bruno S, et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006; 38: 485-9. doi: https://doi.org/10.1016/j.dld.2006.03.021
28. Lee SS, Park SH, Kim HJ, Kim SY, Kim MY, Kim DY, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 2010; 52: 579-85. doi: https://doi.org/10.1016/j.jhep.2010.01.008
29. van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology . 2010; 256: 159-68. doi: https://doi.org/10.1148/radiol.10091790
30. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-90. doi: https://doi.org/10.1002/hep.24452
31. Bril F, Ortiz-Lopez C, Lomonaco R, Orsak B, Freckleton M, Chintapalli K, et al. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients. Liver Int 2015; 35: 2139-46. doi: https://doi.org/10.1111/liv. 12840
32. Debongnie JC, Pauls C, Fievez M, Wibin E. Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Gut 1981; 22: 130-5. doi: https://doi.org/10.1136/gut.22.2.130
33. Mathiesen UL, Franzen LE, Aselius H, Resjo M, Jacobsson L, Foberg U, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002; 34: 516-22. doi: https://doi.org/10.1016/S1590-8658(02)80111-6
34. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50.doi:https://doi.org/10.1053/gast.2002.35354
35. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986; 292: 13-15. doi: https://doi.org/10.1136/bmj.292.6512.13
36. Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 2007; 189: W320-W323. doi: https://doi.org/10.2214/AJR.07.2123
37. Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB. Fatty liver: imaging patterns and pitfalls. Radiographics 2006; 26: 1637-53. doi: https://doi.org/10.1148/rg.266065004
38. Xu L, Lu W, Li P, Shen F, M i YQ, Fan JG. A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B. Dig Liver Dis 2017; 49: 910-7. doi: https://doi.org/10.1016/j.dld.2017.03.013
39. Paige JS, Bernstein GS, Heba E, Costa EAC, Fereirra M, Wolfson T, et al. A pilot comparative study of quantitative ultrasound, conventional ultrasound, and M R I for predicting histology-determined steatosis grade i n adult nonalcoholic fatty liver disease. AJR Am J Roentgenol 2017; 208: W168-W177. doi: https://doi.org/10.2214/AJR.16.16726
40. Han A, Andre MP, Erdman JW, Loomba R, Sirlin CB, O'Brien WD. Repeatability and reproducibility of a clinically based QUS phantom study and methodologies. IEEE Trans Ultrason Ferroelectr Freq Control 2017; 64: 218-31. doi: https://doi.org/10.1109/ TUFFC.2016.2588979
41. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980; 137: 727-9. doi: https://doi.org/10.1148/radiology.137.3.6934563
42. Boyce CJ, Pickhardt PJ, K i m D H, Taylor AJ, Winter TC, Bruce RJ, et al. Hepatic steatosis (fatty liver disease) i n asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 2010; 194: 623-8. doi: https://doi.org/10.2214/AJR.09.2590
43. Wells M M, Li Z, Addeman B, McKenzie CA, Mujoomdar A, Beaton M, et al. Computed tomography measurement of hepatic steatosis: prevalence of hepatic steatosis in a canadian population. Can J Gastroenterol Hepatol 2016; 2016: 1-7. doi: https://doi.org/10.1155/2016/4930987
44. Park YS, Park SH, Lee SS, Kim DY, Shin YM, Lee W, et al. Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology 2011; 258: 760-6. doi: https://doi.org/10.1148/radiol.10101233
45. Johnston RJ, Stamm ER, Lewin JM, Hendrick RE, Archer PG. Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements. Abdom Imaging 1998; 23: 409-15. doi: https://doi.org/10.1007/s002619900370
46. Jacobs JE, Birnbaum BA, Shapiro M A, Langlotz CP, Slosman F, Rubesin SE, et al. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. AJR Am J Roentgenol 1998; 171: 659-64. doi: https://doi.org/10.2214/ajr.17L3.9725292
47. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 2011; 21: 87-97. doi: https://doi.org/10.1007/s00330-010-1905-5
48. Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, Yu ES. Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol 2012; 22: 1075-82. doi: https://doi.org/10.1007/s00330-011-2349-2
49. Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006; 239: 105-12. doi: https://doi.org/10.1148/radiol.2391050361
50. Kramer H, Pickhardt PJ, Kliewer MA, Hernando D, Chen GH, Zagzebski JA, et al. Accuracy of liver fat quantification with advanced CT, MRI, and ultrasound techniques: prospective comparison with MR spectroscopy. AJR Am J Roentgenol 2017; 208: 92-100. doi: https://doi.org/10.2214/AJR.16.16565
51. Kim DY, Park SH, Lee SS, Kim HJ, Kim SY, Kim MY, et al. Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. Eur Radiol 2010; 20: 359-66. doi: https://doi.org/10.1007/ s00330-009-1560-x
52. Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007; 188: 1307-12. doi: https://doi.org/10.2214/AJR.06.0992
53. Fischer MA, Gnannt R, Raptis D, Reiner CS, Clavien P-A, Schmidt B, et al. Quantification of liver fat in the presence of iron and iodine. Invest Radiol 2011; 46: 351-8. doi: https://doi.org/10.1097/RLI. 0b013e31820e1486
54. Zheng D, Tian W, Zheng Z, Gu J, Guo Z, He X. Accuracy of computed tomography for detecting hepatic steatosis in donors for liver transplantation: a meta-analysis. Clin Transplant 2017; 31: e13013. doi: https://doi.org/10.1111/ctr.13013
55. Artz NS, Hines CD, Brunner ST, Agni RM, Kiihn JP, Roldan-Alzate A, et al. Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse. Invest Radiol 2012; 47: 603-10. doi: https://doi.org/10.1097/RLI. 0b013e318261fad0
56. Hyodo T, Hori M, Lamb P, Sasaki K, Wakayama T, Chiba Y, et al. Multimaterial decomposition algorithm for the quantification of liver fat content by using fast-kilovolt-peak switching dual-energy CT: experimental validation. Radiology 2017; 282: 381-9. doi: https://doi.org/10.1148/radiol.2016160129
57. Hamilton G, Middleton MS, Heba ER, Sirlin CB. Imaging techniques for the assessment of ectopic fat in liver and skeletal muscle. In: Translational research methods for diabetes, obesity and cardiometabolic drug development [Internet]. London: Springer London; 2015. pp. 99-119. http://link.springer.com/10.1007/978-1-4471-4920-0_4.
58. Hamilton G, Yokoo T, Bydder M, Cruite I, Schroeder ME, Sirlin CB, et al. In vivo characterization of the liver fat ' H MR spectrum. NMR Biomed 2011; 24: 784-90. doi: https://doi.org/10.1002/nbm.1622
59. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011; 34: 729-49. doi: https://doi.org/10.1002/jmri. 22580
60. Hong CW, Fazeli Dehkordy S, Hooker JC, Hamilton G, Sirlin CB. Fat quantification in the abdomen. Top Magn Reson Imaging 2017; 26: 221-7. doi: https://doi.org/10.1097/RMR. 0000000000000141
61. Meisamy S, Hines CD, Hamilton G, Sirlin CB, McKenzie CA, Yu H, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011; 258: 767-75. doi: https://doi.org/10.1148/radiol. 10100708
62. Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009; 251: 67-76. doi: https://doi.org/10.1148/radiol. 2511080666
63. Choi SS, Diehl AM. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr Opin Lipidol 2008; 19: 295-300. doi: https://doi.org/10.1097/MOL. 0b013e3282ff5e55
64. Zand KA, Shah A, Heba E, Wolfson T, Hamilton G, Lam J, et al. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children. J Magn Reson Imaging 2015; 42: 1223-32. doi: https://doi.org/10.1002/jmri.24888
65. Yokoo T, Serai SD, Pirasteh A, Bashir MR, Hamilton G, Hernando D, et al. Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology 2018; 286: 486-98. doi: https://doi.org/10.1148/radiol.2017170550
66. Achmad E, Yokoo T, Hamilton G, Heba ER, Hooker JC, Changchien C, et al. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease. Abdom Imaging 2015; 40: 3084-90. doi: https://doi.org/10.1007/s00261-015-0506-9
67. Rehm JL, Wolfgram PM, Hernando D, Eickhoff JC, Allen DB, Reeder SB. Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol 2015; 25: 2921-30. d o i: https://doi.org/10.1007/s00330-015-3724-1
68. Haufe W M, Wolfson T, Hooker CA, Hooker JC, Covarrubias Y, Schlein AN, et al. Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference. J Magn Reson Imaging 2017; 46: 1641-7. doi: https://doi.org/10.1002/jmri.25699
69. Satkunasingham J, N i k H H, Fischer S, Menezes R, Selzner N, Cattral M, et al. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy i n potential liver donors? Liver Transplantation 2018; 24: 470-7. doi: https://doi.org/10.1002/lt.24965
70. Artz NS, Haufe W M, Hooker CA, Hamilton G, Wolfson T, Campos GM, et al. Reproducibility of MR-based liver fat quantification across field strength: same-day comparison between 1.5T and 3T in obese subjects. J Magn Reson Imaging 2015; 42: 811-7. doi: https://doi.org/10.1002/jmri. 24842
71. Kang GH, Cruite I, Shiehmorteza M, Wolfson T, Gamst AC, Hamilton G, et al. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging 2011; 34: 928-34. doi: https://doi.org/10.1002/jmri.22701
72. Bannas P, Kramer H, Hernando D, Agni R, Cunningham AM, Mandal R, et al. Quantitative magnetic resonance imaging of hepatic steatosis: validation in ex vivo human livers. Hepatology 2015; 62: 1444-55. doi: https://doi.org/10.1002/hep.28012
73. Tyagi A, Yeganeh O, Levin Y, Hooker JC, Hamilton GC, Wolfson T, et al. Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults. Abdom Imaging 2015; 40: 3070-7. doi: https://doi.org/10.1007/s00261-015-0542-5
74. Lee SW, Park SH, Kim KW, Choi EK, Shin YM, Kim PN, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 2007; 244: 479-85. doi: https://doi.org/10.1148/radiol.2442061177
75. Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013; 267: 767-75. doi: https://doi.org/10.1148/radiol.13121360
76. Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015; 274: 416-25. doi: https://doi.org/10.1148/radiol. 14140754
77. Middleton MS, Heba ER, Hooker CA, Bashir MR, Fowler KJ, Sandrasegaran K, et al. Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 2017; 153: 753-61. doi: https://doi.org/10.1053/j.gastro.2017.06.005
78. Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013; 58: 1930-40. doi: https://doi.org/10.1002/hep.26455
79. Loomba R, Sirlin CB, Ang B, Bettencourt R, Jain R, Salotti J, et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 2015; 61: 1239-50. doi: https://doi.org/10.1002/hep. 27647
80. Cui J, Philo L, Nguyen P, Hofflich H, Hernandez C, Bettencourt R, et al. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol 2016; 65: 369-76. doi: https://doi.org/10.1016/j.jhep.2016.04.021
81. Lin SC, Heba E, Bettencourt R, Lin GY, Valasek MA, Lunde O, et al. Assessment of treatment response in non-alcoholic steatohepatitis using advanced magnetic resonance imaging. Aliment Pharmacol Ther 2017; 45: 844-54. doi: https://doi.org/10.1111/apt.13951
82. Negrete LM, Middleton MS, Clark L, Wolfson T, Gamst AC, Lam J, et al. Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects. J Magn Reson Imaging 2014; 39: 1265-71. doi: https://doi.org/10.1002/jmri. 24284
83. Hong CW, Mamidipalli A, Hooker JC, Hamilton G, Wolfson T, Chen DH, et al. MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis. J Magn Reson Imaging 2018; 47: 995-1002. doi: https://doi.org/10.1002/jmri.25845
84. Heba ER, Desai A, Zand KA, Hamilton G, Wolfson T, Schlein AN, et al. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. J Magn Reson Imaging 2016; 43: 398-406. doi: https://doi.org/10.1002/jmri.25006
85. Nasr P, Forsgren MF, Ignatova S, Dahlstrom N, Cedersund G, Leinhard OD, et al. Using a 3% proton density fat fraction as a cut-off value increases sensitivity of detection of hepatic steatosis, based on results from histopathology analysis. Gastroenterology 2017; 153: 53-5. doi: https://doi.org/10.1053/j.gastro.2017.03.005